Hoping US drug pricing might improve under Biden now Trump looks to be out of the picture and his relentless war on drug pricing . Contributions toward Biden's push for presidency by drug companies and related interests were something like US 2.5 M so expect they'd be expecting some consideration based on their investment in him . Mayne now mainly focused and set up in the States and provided our Major approvals come in enough sales after production and provided we remain a ASX listed company not taken over or needing another cap raising . Who knows whats going to happen down the track but we certainly cant afford another cock up under SR ( our biggest risk) can only hope for the best and all LT holders break even sometime in the new year .
MYX Price at posting:
31.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)